Skip to main content

Advertisement

Fig. 5 | BMC Medical Research Methodology

Fig. 5

From: The use of single armed observational data to closing the gap in otherwise disconnected evidence networks: a network meta-analysis in multiple myeloma

Fig. 5

SUCRA scores of analyses connecting separate networks of evidence. Shows ranking of model including all connecting matches simultaneously as well as models investigating each match individually. bev = bevacizumab; bor = bortezomib; carf = carfilzomib; cyc = cyclophosphamide; dara = daratumumab; dex = dexamethasone; elo = elozumatab; IFN = interferon alpha; ixa = ixazomib; len = lenalidomide; ob = oblimersen; pan = panobinostat; peri = perifosine; PLD = pegylated liposomal doxorubicin; pom = pomalidomide; sil = silituximab; thal = thalidomide; vor = vorinostat

Back to article page